{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T03:42:43Z","timestamp":1772768563132,"version":"3.50.1"},"reference-count":25,"publisher":"Japan Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1507\/endocrj.ej23-0659","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T22:13:47Z","timestamp":1710368027000},"page":"489-497","source":"Crossref","is-referenced-by-count":1,"title":["Primary aldosteronism patients with previous cardiovascular and cerebrovascular events have high aldosterone responsiveness to ACTH stimulation"],"prefix":"10.1507","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6855-3926","authenticated-orcid":false,"given":"Eriko","family":"Nakano","sequence":"first","affiliation":[{"name":"Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9365-5561","authenticated-orcid":false,"given":"Kosuke","family":"Mukai","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6289-3778","authenticated-orcid":false,"given":"Atsunori","family":"Fukuhara","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan"},{"name":"Department of Adipose Management, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5947-8621","authenticated-orcid":false,"given":"Michio","family":"Otsuki","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Tokyo Woman\u2019s Medical University, Tokyo 162-8666, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0851-9603","authenticated-orcid":false,"given":"Iichiro","family":"Shimomura","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2969-7396","authenticated-orcid":false,"given":"Takamasa","family":"Ichijo","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Saiseikai Yokohamashi Tobu Hospital, Kanagawa 230-8765, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Tsuiki","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9796-4890","authenticated-orcid":false,"given":"Norio","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Sapporo City General Hospital, 060-8604 Hokkaido, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0921-158X","authenticated-orcid":false,"given":"Takashi","family":"Yoneda","sequence":"additional","affiliation":[{"name":"Department of Health Promotion and Medicine of the Future, Graduate School of Medical Sciences, Kanazawa University, Ishikawa 920-8640, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5670-8871","authenticated-orcid":false,"given":"Yoshiyu","family":"Takeda","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Asanogawa General Hospital, Ishikawa 920-8621, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8275-6295","authenticated-orcid":false,"given":"Kenji","family":"Oki","sequence":"additional","affiliation":[{"name":"Department of Molecular and Internal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8519, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0834-2836","authenticated-orcid":false,"given":"Yoshihiro","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyusyu University, Fukuoka 812-8582, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5334-7687","authenticated-orcid":false,"given":"Daisuke","family":"Yabe","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism and Department of Rheumatology and Clinical Immunology, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7112-1585","authenticated-orcid":false,"given":"Miki","family":"Kakutani","sequence":"additional","affiliation":[{"name":"Division of Diabetes, Endocrinology, and Clinical Immunology, Department of Internal Medicine, Hyogo College of Medicine, Hyogo 663-8501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0757-7529","authenticated-orcid":false,"given":"Masakatsu","family":"Sone","sequence":"additional","affiliation":[{"name":"Division of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa 216-8511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0396-8645","authenticated-orcid":false,"given":"Takuyuki","family":"Katabami","sequence":"additional","affiliation":[{"name":"Division of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine Yokohama City Seibu Hospital, Kanagawa 241-0811, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5682-4952","authenticated-orcid":false,"given":"Akiyo","family":"Tanabe","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, National Center for Global Health and Medicine, Tokyo 162-8655, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8977-4090","authenticated-orcid":false,"given":"Mitsuhide","family":"Naruse","sequence":"additional","affiliation":[{"name":"Endocrine Center, Ijinkai Takeda General Hospital, Kyoto 601-1495, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"JPAS\/JRAS Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, et al. (2008) Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical guideline. J Clin Endocrinol Metab 93: 3266\u20133281.","DOI":"10.1210\/jc.2008-0104"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Mulatero P, Monticone S, Bertello C, Viola A, Tizzani D, et al. (2013) Long-term cardio- and cerebrovascular events in patients with primary aldosteronism. J Clin Endocrinol Metab 98: 4826\u20134833.","DOI":"10.1210\/jc.2013-2805"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, et al. (2005) Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 45: 1243\u20131248.","DOI":"10.1016\/j.jacc.2005.01.015"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Murata M, Kitamura T, Tamada D, Mukai K, Kurebayashi S, et al. (2017) Plasma aldosterone level within the normal range is less associated with cardiovascular and cerebrovascular risk in primary aldosteronism. J Hypertens 35: 1079\u20131085.","DOI":"10.1097\/HJH.0000000000001251"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5 Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, et al. (2018) Prevalence of cardiovascular disease and its risk factors in primary aldosteronism: a multicenter study in Japan. Hypertension 71: 530\u2013537.","DOI":"10.1161\/HYPERTENSIONAHA.117.10263"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Nanba K, Yamazaki Y, Bick N, Onodera K, Tezuka Y, et al. (2020) Prevalence of somatic mutations in aldosterone-producing adenomas in Japanese patients. J Clin Endocrinol Metab 105: e4066\u2013e4073.","DOI":"10.1210\/clinem\/dgaa595"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Zwermann O, Suttmann Y, Bidlingmaier M, Beuschlein F, Reincke M (2009) Screening for membrane hormone receptor expression in primary aldosteronism. Eur J Endocrinol 160: 443\u2013451.","DOI":"10.1530\/EJE-08-0711"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 St-Jean M, Bourdeau I, Martin M, Lacroix A (2021) Aldosterone is aberrantly regulated by various stimuli in a high proportion of patients with primary aldosteronism. J Clin Endocrinol Metab 106: e45\u2013e60.","DOI":"10.1210\/clinem\/dgaa703"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Lacoix A, Baldacchino V, Bourdeau I, Hamet P, Tremblay J (2004) Cushing\u2019s syndrome variants secondary to aberrant hormone receptors. Trends Endocrinol Metab 15: 375\u2013382.","DOI":"10.1016\/j.tem.2004.08.007"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Lampron A, Bourdeau I, Oble S, Godbout A, Sch\u00fcrch W, et al. (2009) Regulation of aldosterone secretion by several aberrant receptors including for glucose-dependent insulinotropic peptide in a patient with an aldosteronoma. J Clin Endocrinol Metab 94: 750\u2013756.","DOI":"10.1210\/jc.2008-1340"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Albiger NM, Sartorato P, Mariniello B, Iacobone M, Finco I, et al. (2011) A case of primary aldosteronism in pregnancy: do LH and GNRH receptors have a potential role in regulating aldosterone secretion? Eur J Endcrinol 164: 405\u2013412.","DOI":"10.1530\/EJE-10-0879"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Rossi GP, Ganzaroli C, Cesari M, Maresca A, Plebani M, et al. (2003) Endothelin receptor blockade lowers plasma aldosterone levels <i>via<\/i> different mechanisms in primary aldosteronism and high-to-normal renin hypertension. Cardiovasc Res 57: 277\u2013283.","DOI":"10.1016\/S0008-6363(02)00658-2"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Sonoyama T, Sone M, Tamura N, Honda K, Taura D, et al. (2014) Role of endogenous ACTH on circadian aldosterone rhythm in patients with primary aldosteronism. Endocr Connect 3: 173\u2013179.","DOI":"10.1530\/EC-14-0086"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Nakajima Y, Yamada M, Taguchi R, Satoh T, Hashimoto K, et al. (2011) Cardiovascular complications of patients with aldosteronism associated with autonomous cortisol secretion. J Clin Endocrinol Metab 96: 2512\u20132518.","DOI":"10.1210\/jc.2010-2743"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Naruse M, Katabami T, Shibata H, Sone M, Takahashi K, et al. (2022) Japan endocrine society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021. Endocr J 69: 327\u2013359.","DOI":"10.1507\/endocrj.EJ21-0508"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Nakai M, Watanabe M, Kokubo Y, Nishimura K, Higashiyama A, et al. (2020) Development of a cardiovascular disease risk prediction model using the Suita Study, a population-based prospective cohort study in Japan. J Atheroscler Thromb 27: 1160\u20131175.","DOI":"10.5551\/jat.48843"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Haffner SM, Lehto S, R\u00f6nnemaa T, Py\u00f6r\u00e4l\u00e4 K, Laakso M (1998) Mortality from coronary heart disease in subjects with type2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339: 229\u2013234.","DOI":"10.1056\/NEJM199807233390404"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18 Imamura T, Doi Y, Arima H, Yonemoto K, Hata J, et al. (2009) LDL cholesterol and the development of stroke subtypes and coronary heart disease in a general Japanese population: the Hisayama study. Stroke 40: 382\u2013388.","DOI":"10.1161\/STROKEAHA.108.529537"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Hata J, Doi Y, Ninomiya T, Fukuhara M, Ikeda F, et al. (2011) Combined effects of smoking and hypercholesterolemia on the risk stroke and coronary heart disease in Japanese: the Hisayama study. Cerebrovasc Dis 31: 477\u2013484.","DOI":"10.1159\/000324392"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20 Kokubo Y, Nakamura S, Okamura T, Yoshimasa Y, Makino H, et al. (2009) Relationship between blood pressure category and incidence of stroke and myocardial infarction in an urban Japanese population with and without chronic kidney disease: the Suita Study. Stroke 40: 2674\u20132679.","DOI":"10.1161\/STROKEAHA.109.550707"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Wehling M, Spes CH, Win N, Janson CP, Schmidt BM, et al. (1998) Rapid cardiovascular action of aldosterone in man. J Clin Endocrinol Metab 83: 3517\u20133522.","DOI":"10.1210\/jc.83.10.3517"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22 Romagni P, Rossi F, Guerrini L, Quirini C, Santiemma V (2003) Aldosterone induces contraction of the resistance arteries in man. Atherosclerosis 166: 345\u2013349.","DOI":"10.1016\/S0021-9150(02)00363-5"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Schmidt BM, Montealegre A, Janson CP, Martin N, Stein-Kemmesies C, et al. (1999) Short term cardiovascular effects of aldosterone in healthy male volunteers. J Clin Endocrinol Metab 84: 3528\u20133533.","DOI":"10.1210\/jcem.84.10.6020"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24 Mancia G, Bombelli M, Facchetti R, Madotto F, Corrao G, et al. (2007) Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study. Hypertension 49: 1265\u20131270.","DOI":"10.1161\/HYPERTENSIONAHA.107.088708"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Lim JS, Plaska SW, Rege J, Rainey WE, Turcu AF (2021) Aldosterone-regulating receptors and aldosterone-driver somatic mutations. Front Endocrinol (Lausanne) 12: 644382.","DOI":"10.3389\/fendo.2021.644382"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/71\/5\/71_EJ23-0659\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T04:31:57Z","timestamp":1716611517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/71\/5\/71_EJ23-0659\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej23-0659","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"EJ23-0659"}}